Zurich, Switzerland

Holger Koch

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Zurich, CH (2016)
  • Zürich, CH (2016)
  • San Jose, CA (US) (2018)

Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Holger Koch: Innovator in Monoclonal Antibody Development

Introduction

Holger Koch is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of three patents to his name, Koch's work focuses on innovative solutions for treating viral infections.

Latest Patents

Koch's latest patents include a human monoclonal antibody specific for the F protein of respiratory syncytial virus (RSV). This invention is directed to an antibody construct or fragment derived from an RSV-infected human. The antibody construct binds with specificity to the RSV fusion protein antigenic region II/A with an affinity of greater than 1×10^10 M. It is designed to neutralize RSV strains, including at least one strain resistant to palivizumab. The invention also encompasses nucleic acids encoding the antibody construct and cell lines expressing the antibody. Furthermore, it relates to methods for producing the antibody construct and its use in treating or preventing RSV infections in patients.

Career Highlights

Throughout his career, Holger Koch has worked with notable companies, including Aridis Pharmaceuticals. His expertise in antibody development has positioned him as a key player in the biotechnology sector.

Collaborations

Koch has collaborated with esteemed colleagues, including Michael Rudolf and Simon Urwyler. These partnerships have further enhanced his research and development efforts in the field of monoclonal antibodies.

Conclusion

Holger Koch's innovative work in monoclonal antibody development has the potential to significantly impact the treatment of viral infections. His contributions to biotechnology exemplify the importance of research and collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…